Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The First Sphingosine 1-Phosphate Lyase Inhibitors against Multiple Sclerosis: A Successful Drug Discovery Tale.
Vitamin D in allergic disorders.
A rare case of multiple sclerosis and McArdle disease.
Paraneoplastic Neuromyelitis Optica Spectrum Disorders: Three New Cases and A Review of the Literature.
[Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis].
JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression.
Cellular senescence and the aging brain.
High variability of fabry disease manifestations in an extended italian family.
Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene.
Response to IV immunoglobulin in a case of osmotic demyelination syndrome.
Integrin-linked kinase regulates oligodendrocyte cytoskeleton, growth cone, and adhesion dynamics.
Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Employment and multiple sclerosis: Policy, programming, and research recommendations.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Longitudinal associations between MRI and cognitive changes in very early MS.
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
Urinary tract infections in multiple sclerosis.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases.
Pages
« first
‹ previous
…
483
484
485
486
487
488
489
490
491
…
next ›
last »